Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03752268
Other study ID # 13-614
Secondary ID ACS MRSG 14-107-
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 15, 2014
Est. completion date November 30, 2022

Study information

Verified date May 2021
Source Massachusetts General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research study is being done to understand how patients with chronic cancer pain take their long-acting opioid medications, and to develop an intervention to enhance cancer pain management.


Description:

Long-acting opioids are a common treatment for cancer pain. The purpose of this study is to develop a program for patients who are taking a prescribed long-acting opioid for their cancer pain. Participants will be enrolled in this study at the Massachusetts General Hospital Cancer Center. This 14-week study involves completing a set of questionnaires at three different times during the study period. . During the study period, participants will use electronic pill caps to monitor their pain medication taking. They also will attend a series of three visits with one of the nurse practitioners on their care cancer team. The visits will focus on learning and practicing skills for managing cancer pain. The information that the investigators collect will help identify whether the sessions are feasible and useful to patients during the course of treatment for cancer pain. This trial will consist of two parts: Part 1: This is a single-group prospective observational study. Investigators will use quantitative and qualitative methods to examine rates, predictors and outcomes of adherence to LA opioids over a period of approximately eight weeks. This information will be used to inform Part 2 intervention development and testing. Part 2: Investigators will test the behavioral intervention in a non-randomized open pilot, over a period of approximately six weeks. Intervention process data, psychosocial and medical data, and post-intervention feedback will be collected to assess feasibility and acceptability. In an iterative process, ongoing data from exit interviews and therapist experience will be used to modify the intervention protocol.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 150
Est. completion date November 30, 2022
Est. primary completion date November 30, 2021
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Age 21 or older - Currently prescribed a long-acting (LA) opioid for nociceptive cancer pain (extended release oxycodone, extended-release morphine, transdermal fentanyl patches, methadone tablets) - Ability to comprehend study materials in English - Eastern Cooperative Oncology Group (ECOG) performance status = 2 - In charge of administering own pain medications - Part 2 study only: within 4 months of current prescription of LA opioid for nociceptive cancer pain Exclusion Criteria: - Impaired cognition, active substance disorder, or other active, unstable mental health disorder - Current long-acting opioid treatment for pre-existing condition - Part 2 study only: Prior enrollment in the Part 1 study**

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Enhancing Cancer Pain Management
Patients will learn and practice an enduring framework of cognitive-behavioral strategies, to enhance adherence behavior, reduce intentional and unintentional deviations from the prescribed regimen.

Locations

Country Name City State
United States Massachusetts General Hospital Cancer Center Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Massachusetts General Hospital American Cancer Society, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants who complete study sessions Proportion of enrolled participants who complete the study, based on a criterion of greater than or equal to 75% completed sessions. 2 Years
Primary Number of participants who identify study components as acceptable Individual response frequencies of 4 Likert-type scale items, designed for this study, that rate acceptability of 1) number of study sessions, 2) length of study sessions, 3) usefulness of study material, and 4) impact of study material on pain management, and themes of two free-text items that elicit unstructured participant feedback about acceptability of these study components. 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT04340024 - Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Active, not recruiting NCT03609177 - Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly N/A
Active, not recruiting NCT04591431 - The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy Phase 2
Recruiting NCT06103669 - Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS) N/A
Recruiting NCT04585750 - The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) Phase 1/Phase 2
Recruiting NCT03160274 - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Completed NCT03736746 - Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals N/A
Completed NCT03638453 - Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention N/A
Recruiting NCT06397651 - A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of Care N/A
Active, not recruiting NCT03850912 - Symptom Management Implementation of Patient Reported Outcomes in Oncology N/A
Completed NCT03392090 - SHARE (Sharing Goals and Preferences) Study N/A
Completed NCT03244826 - Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation N/A
Recruiting NCT03517332 - Circulating Tumor DNA Exposure in Peripheral Blood
Completed NCT03721926 - A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer N/A
Active, not recruiting NCT03967379 - Multimodal Mobile Intervention Application (App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors N/A
Completed NCT05176860 - Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy N/A
Active, not recruiting NCT03674047 - Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT) Phase 2